Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
31M
-
Shares change
-
+718K
-
Total reported value, excl. options
-
$463M
-
Value change
-
-$1.25M
-
Put/Call ratio
-
0.73
-
Number of buys
-
55
-
Number of sells
-
-32
-
Price
-
$15.09
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q4 2021
113 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q4 2021.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31M shares
of 92.2M outstanding shares and own 33.58% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (4.09M shares), FMR LLC (3.32M shares), FARALLON CAPITAL MANAGEMENT LLC (2.96M shares), Avidity Partners Management LP (2.67M shares), PICTET ASSET MANAGEMENT SA (1.92M shares), BlackRock Inc. (1.76M shares), ALKEON CAPITAL MANAGEMENT LLC (1.25M shares), JANUS HENDERSON GROUP PLC (1.17M shares), VANGUARD GROUP INC (915K shares), and FIL Ltd (861K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.